Ripasudil Monohydrochloride Dihydrate is a Rho-kinase inhibitor derived from fasudil that is indicated for the treatment of glaucoma and ocular hypertension. This category encompasses the active pharmaceutical… Read more
Ripasudil Monohydrochloride Dihydrate is a Rho-kinase inhibitor derived from fasudil that is indicated for the treatment of glaucoma and ocular hypertension. This category encompasses the active pharmaceutical ingredient along with a range of related compounds, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled standards. These materials are essential for pharmaceutical laboratories performing rigorous analytical testing, method validation, and quality control procedures. By providing characterized reference standards, these compounds enable accurate impurity profiling and precise quantification during stability studies and batch release testing. Utilizing these specialized materials ensures that analytical methods can reliably detect, identify, and monitor degradation products or synthesis-related impurities, maintaining high standards of regulatory compliance and drug safety throughout the development and manufacturing lifecycle.